Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

It has good news in hand and plenty of room to grow.

Unpacking the Latest Options Trading Trends in Iovance Biotherapeutics ↗

February 23, 2024

Via Benzinga

This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst ↗

February 23, 2024

These two businesses have viable paths to making investors richer -- possibly soon.

2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value ↗

February 23, 2024

Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024

Iovance Biotherapeutics Unusual Options Activity For February 22 ↗

February 22, 2024

Via Benzinga

February 22, 2024

Iovance is no longer a clinical-stage biotech.

Why Iovance Biotherapeutics Stock Is Skyrocketing Today ↗

February 20, 2024

It will take a while for its risks to resolve.

Is Iovance Biotherapeutics Stock a Buy Now? ↗

February 08, 2024

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗

February 22, 2024

MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.

Via Talk Markets

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 21, 2024

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 21, 2024

Via Benzinga

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Wednesday Trading

February 21, 2024

Via Investor Brand Network

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday ↗

February 21, 2024

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Why Is Iovance Therapeutics (IOVA) Stock Up 35% Today? ↗

February 20, 2024

With Iovance Therapeutics gaining FDA approval for its novel skin cancer therapeutic, IOVA stock is proving the bears wrong.

Via InvestorPlace

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 20, 2024

Via Benzinga

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Tuesday Trading

February 20, 2024

Via Investor Brand Network

Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday ↗

February 20, 2024

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.

Via Benzinga

Topics Stocks

What's Going On With Iovance Biotherapeutics Stock? ↗

February 20, 2024

Iovance Biotherapeutics announced Tuesday that the U.S. Food and Drug Administration (FDA) approved the company to begin analytical testing and manufacturing of AMTAGVI at its Philadelphia site....

Via Benzinga

Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 20, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

February 20, 2024

Shares of Discover Financial Services (NYSE: DFS) shares rose sharply in today’s pre-market trading.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 20, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 20, 2024

Pre-market stock movers are a hot topic on Tuesday morning as we start the day with a breakdown of all the latest stock market news!

Via InvestorPlace

Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock

February 20, 2024

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 19, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

February 19, 2024

Via Benzinga

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

February 16, 2024

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024

February 16, 2024

Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma

February 16, 2024

The potential pitfall could be dire, but the odds seem to be in the biotech's favor.

3 Opportunities for Iovance Biotherapeutics Stock, and 1 Risk ↗

February 12, 2024